Northern Trust Corp Insmed Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Insmed Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,459,964 shares of INSM stock, worth $96.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,459,964

Previous 1,392,107 4.87%

Holding current value

$96.8 Million

Previous $93.3 Million 14.27%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$62.0 - $79.01 $4.21 Million - $5.36 Million	67,857 Added 4.87%	1,459,964 $107 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $1.22 Million - $3.86 Million	55,310 Added 4.14%	1,392,107 $93.3 Million
Q1 2024 May 14, 2024	SELL	$25.72 - $29.94 $911,722 - $1.06 Million	-35,448 Reduced 2.58%	1,336,797 $36.3 Million
Q4 2023 Feb 13, 2024	BUY	$23.42 - $31.74 $604,540 - $819,304	25,813 Added 1.92%	1,372,245 $42.5 Million
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $434,437 - $589,093	21,875 Added 1.65%	1,346,432 $34 Million
Q2 2023 Aug 11, 2023	BUY	$16.44 - $21.1 $346,473 - $444,682	21,075 Added 1.62%	1,324,557 $27.9 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $42,877 - $57,302	2,637 Added 0.2%	1,303,482 $22.2 Million
Q4 2022 Feb 13, 2023	BUY	$16.98 - $23.15 $2.47 Million - $3.37 Million	145,517 Added 12.6%	1,300,845 $26 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $90,723 - $122,572	-4,345 Reduced 0.37%	1,155,328 $24.9 Million
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $424,104 - $638,764	-24,845 Reduced 2.1%	1,159,673 $22.9 Million
Q1 2022 May 13, 2022	SELL	$20.42 - $28.13 $780,003 - $1.07 Million	-38,198 Reduced 3.12%	1,184,518 $27.8 Million
Q4 2021 Feb 08, 2022	BUY	$25.89 - $33.45 $558,602 - $721,717	21,576 Added 1.8%	1,222,716 $33.3 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $1.12 Million - $1.47 Million	50,017 Added 4.35%	1,201,140 $33.1 Million
Q2 2021 Aug 13, 2021	BUY	$24.17 - $36.01 $860,935 - $1.28 Million	35,620 Added 3.19%	1,151,123 $32.8 Million
Q1 2021 May 12, 2021	SELL	$32.28 - $44.3 $1.49 Million - $2.04 Million	-46,117 Reduced 3.97%	1,115,503 $38 Million
Q4 2020 Feb 11, 2021	SELL	$31.45 - $40.54 $840,784 - $1.08 Million	-26,734 Reduced 2.25%	1,161,620 $38.7 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $2.1 Million - $2.79 Million	-80,874 Reduced 6.37%	1,188,354 $38.2 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $2.65 Million - $5.53 Million	188,132 Added 17.4%	1,269,228 $35 Million
Q1 2020 May 14, 2020	BUY	$13.63 - $33.98 $217,316 - $541,777	15,944 Added 1.5%	1,081,096 $17.3 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $851,619 - $1.32 Million	-52,830 Reduced 4.73%	1,065,152 $25.4 Million
Q3 2019 Nov 13, 2019	BUY	$15.49 - $25.78 $2.16 Million - $3.6 Million	139,531 Added 14.26%	1,117,982 $19.7 Million
Q2 2019 Aug 13, 2019	BUY	$23.0 - $32.19 $685,331 - $959,165	29,797 Added 3.14%	978,451 $25 Million
Q1 2019 May 13, 2019	BUY	$13.91 - $31.15 $125,649 - $281,377	9,033 Added 0.96%	948,654 $27.6 Million
Q4 2018 Feb 12, 2019	SELL	$11.6 - $18.7 $790,203 - $1.27 Million	-68,121 Reduced 6.76%	939,621 $12.3 Million
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $388,740 - $576,033	20,514 Added 2.08%	1,007,742 $20.4 Million
Q2 2018 Sep 18, 2018	SELL	$20.0 - $29.72 $100,220 - $148,926	-5,011 Reduced 0.51%	987,228 $23.3 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $701,500 - $1.04 Million	35,075 Added 3.66%	992,239 $23.5 Million
Q1 2018 May 09, 2018	BUY	$21.69 - $32.99 $68,974 - $104,908	3,180 Added 0.33%	957,164 $21.6 Million
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $155,117 - $186,516	5,869 Added 0.62%	953,984 $29.7 Million
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $11 Million - $29.6 Million	948,115	948,115 $29.6 Million

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Insmed Inc Transaction History